WPRIM Management System> DCMS> Korean Journal of Nephrology> 2005> 24

Volume: 24

1. Clinical Significance of Fistulography by Brachial Artery Approach in Hemodialysis Patients. Page:921—928
2. Changes in Flow-Mediated Vasodilation after a Single Session of Hemodialysis. Page:913—920
3. Treatment of Catheter-related Bacteremia with an Antibiotic Lock Protocol in Hemodilaysis Patients. Page:903—911
4. The Reasons for Use of Temporary Catheter Instead of Arteriovenous Fistula at the Start of Chronic Hemodialysis Therapy. Page:895—901
5. Clinical Benefits of On-Line Hemodiafiltration in ESRD Patients. Page:885—893
6. Progression of Diabetic Nephropathy in Type 1 Diabetes in Korea. Page:873—883
7. Epidemiology and Clinical Course of Diabetic Nephropathy; Is There Any Differences in Prevalence and Incidence of Diabetic Nephropathy between Type 1 and Type 2 Diabetes Mellitus?. Page:865—871
8. Polymorphism of Plasminogen Activator Inhibitor-1 and Development of Diabetic Renal Failure in Koreans. Page:223—229
9. Clinical Significance of Urinary G1 Cells in the Differentiation of Hematuria. Page:215—222
10. Empiric Therapy with Cefazolin and Ceftazidime (or Aminoglycoside) is Effective as the Initial Choice for the Treatment of Peritoneal Dialysis Related Peritonitis. Page:204—214
11. The Effect of alpha-MSH on Long-term Histologic Changes after Acute Ischemic Kidney Injury in Rats. Page:191—203
12. Adenovirus-mediated Gene Therapy of Uteroglobin Protects the Experimental Glomerulonephritis in Mice. Page:181—190
13. The Expressions of PDGF-C, PDGF-D and PDGF Receptors in Renal Development Model. Page:170—180
14. Empirical Treatment of CAPD Peritonitis. Page:167—169
15. Chemical Pleurodesis as a Treatment for Hydrothorax Complicating Peritoneal Dialysis. Page:162—166
16. A Case of Third Degree Complete Atrio-Ventricular Block During Catheterization of an Internal Jugular Vein for Hemodialysis. Page:157—161
17. A Case of ReVersible Posterior Leukoencephalopathy Syndrome (RPLS) in a Patients with Chronic Renal Failure. Page:152—156
18. A Case of Idiopathic Light Chain Deposition Disease. Page:146—151
19. A Case of Idiopathic Membranous Glomerulonephritis in association with Thin Glomerular Basement Membrane Nephropathy. Page:141—145
20. A Case of Congenital Single Ectopic Kidney in Pelvis of Patients with Proteinuria. Page:137—140
21. Effects of Walking Exercise Program for Health Status in Patients on Continuous Ambulatory Peritoneal Dialysis. Page:126—136
22. Changes of CA125 and PIIINP (Procollagen-3-N-terminal Peptide) in Peritoneal Dialysis Patients with Low GDP Solution. Page:118—125
23. Prevention of Uncuffed Hemodialysis Catheter-Related Bacteremia (CRB) Using Antibiotic Lock Technique (ALT): A Randomized Controlled Trial. Page:108—117
24. Left Ventricular Longitudinal Diastolic Function and Functional Reserve in ESRD Patients Starting Dialysis Treatment. Page:100—107
25. Association between Left Ventricular Hypertrophy (LVH) and Angiotensin Converting Enzyme (ACE) Gene Polymorphism in Diabetic Nephropathy Patients. Page:90—99
26. Urinary Transforming Growth Factor-beta1 is a Robust Predictor of Kidney Disease Progression. Page:755—762
27. Clinical Utility of Random Spot Urine Protein to Creatinine Ratio Modified by Estimated Daily Creatinine Excretion. Page:749—754
28. The Effect of RNA Interference for TGF-beta1 Overexpression in Rat with Unilateral Ureteral Obstruction. Page:739—748
29. Hypoxia Induces Connective Tissue Growth Factor (CTGF) in Cultured Tubular Cells. Page:729—738
30. Ischemia-Reperfusion Injury Enhances Dendritic Cell Infiltration and TLR2 Expression in Rat Kidneys. Page:718—728
31. High Glucose and Advanced Glycosylation Endproducts (AGE) Modulate the CD2AP Expression in Glomerular Epithelial Cells (GEpC). Page:709—717
32. Effect of Spironolactone on Progression of Nephropathy in Type 2 Diabetic Rat Model. Page:699—708
33. Aldosterone Receptor Blockade Prevents Inflammatory Reaction on Type 2 Diabetic Nephropathy. Page:691—698
34. Renin-Angiotensin-Aldosterone System Blockade and Renal Protection in Diabetic Nephropathy. Page:687—690
35. A Case of Acute Renal Failure Caused by Cresol Ingestion. Page:342—345
36. A Case of Concomitant Interstitial Nephritis by BK Virus with Acute Rejection in a Renal Allograft Recipient. Page:337—341
37. A Case Report of High-turnover Renal Osteodystrophy with Positive Aluminum Staining. Page:332—336
38. A Case of IgA Nephropathy with Systemic Lupus Nephritis. Page:326—331
39. A Case of Minimal Change Disease during Chemotherapy of Bronchogenic Adenocarcinoma. Page:320—325
40. A Case of Idiopathic Nodular Glomerulosclerosis Presenting Rapid Progressive Renal Failure. Page:313—319
41. A Case of ANCA-positive Crescentic Glomerulonephritis after Propylthiouracil Treatment in Graves' Disease. Page:305—312
42. A Case of Asymptomatic Central Pontine Myelinolysis after Severe Hypoglycemia in a Patient with Diabetic Nephropathy. Page:300—304
43. Three Cases of Hyponatremia Caused by Ingestion of Bowel Preparation Solution for Colonoscopy. Page:295—299
44. Clinical Significance of Vesicoureteral Reflux in Renal Transplant Recipients. Page:289—294
45. Clinical Usefulness of Automated Peritoneal Dialysis (APD) in End Stage Renal Disease Patients. Page:280—288
46. Effects of Ginkgo Biloba Extract (GBE) on Hemostatic Factors and Inflammation in Chronic Peritoneal Dialysis (CPD) Patients. Page:274—279
47. Clinical Utility of Access Blood Flow Measurement by Ultrasound Dilution in Hemodialysis Patients. Page:265—273
48. The Effects of On-line Hemodiafiltration on Oxidative Stress and beta2-Microglobulin in Comparison with High-Flux Hemodialysis. Page:255—264
49. Comparison of Safety and Efficiency of Hemodialysis Using Heparin-bound Hemophan with those of Saline Flushing Hemodialysis and Hemodialysis Using Low Dose Heparin in Patients at Risk of Bleeding. Page:246—254
50. B-type Natriuretic Peptide as a Predictor of Cardiovascular Disease in End-Stage Renal Disease Patients Commencing Hemodialysis. Page:239—245
51. Clinical Characteristics of Amyloidosis. Page:230—238
52. A Case of Acute Theophylline Intoxication Treated with Hemoperfusion. Page:860—863
53. Two Cases of Severe Hyperglycemia after Overdose of Amlodipine. Page:856—859
54. A Case of Allopurinol Hypersensitivity Syndrome in a Patient with Chronic Renal Failure. Page:851—855
55. A Case of Primary Aldosteronism with Rhabdomyolysis. Page:845—850
56. A Case of Anti-Glomerular Basement Membrane Gomerulonephritis Superimposed on Preexisting Membranous Nephropathy. Page:838—844
57. A Case of Microscopic Polyangiitis Associated with Paranasal Sinusitis and Pulmonary Hemorrhage. Page:832—837
58. A Case of Lupus Nephritis Associated with Transiently Decreased C1 Inactivator Activity and Angioedema. Page:828—831
59. Clinical Analysis of 19 Renal Transplant Recipients Back from China to Korea. Page:821—827
60. Comparison of Sleep Disturbance in Patients Treated with Hemodialysis, Peritoneal Dialysis and Renal Transplantation. Page:813—820
61. The Change of Lung Diffusing Capacity for Dialysis Duration and Membranes in Maintenance Hemodialysis Patients. Page:805—812
62. Clinical Significance of B-type Natriuretic Peptide Levels and Impedance Cardiography in Maintenance Hemodialysis Patients. Page:797—804
63. The Clinical Significance of Nutrition Assessed by DEXA in Hemodialysis Patients. Page:789—796
64. Survival Differences by Dialysis Modality among Incident End-stage Renal Disease Patients with Preexisting Coronary Artery Disease. Page:778—788
65. Influencing Factors to the Filter Life on Continuous Venovenous Hemodiafiltration without Anticoagulantion. Page:772—777
66. Mycophenolate Mofetil Therapy in Severe Membranous Nephropathy and Diffuse Proliferative Lupus Nephritis: Clinical Observation. Page:763—771
67. 3 Cases of Fenoverine-Induced Rhabdomyolysis. Page:680—685
68. A Case of Graft Intolerance Syndrome Treated by Percutaneous Renal Artery Embolization. Page:674—679
69. Management of Metastatic Thyroid Papillary Carcinoma with Radioiodine in a Patient with Chronic Renal Failure on Hemodialysis. Page:670—673
70. Listeria monocytogenes Meningitis in Hemodialysis Patient: a Case Report. Page:666—669
71. A Case of Erythrocytosis in Long-term Hemodialysis Patient without Erythropoietin Therapy. Page:660—665
72. A Case of Hungry Bone Syndrome after Parathyroidectomy. Page:654—659
73. Osteomyelitis of the Rib Following Internal Jugular Vein Catheter Insertion. Page:650—653
74. A Case of Goodpature's Syndrome with Perinuclear-Antineutrophil Cytoplasmic Antibody. Page:644—649
75. A Case of Mesangial Proliferative Glomerulonephritis Presented with Acute Renal Failure in Patients with lambda Light Chain Type-Multiple Myeloma. Page:638—643
76. A Case of Goodpasture's Syndrome. Page:631—637
77. Multilocular Cystic Renal Cell Carcinoma Accompanied by Autosomal Dominant Polycytstic Kidney Disease. Page:626—630
78. A Case of Anti-glomerular Basement Membrane Disease which Presented with Fever of Unknown Origin. Page:455—459
79. The Cutcome of Living-related Renal Transplantation with Previously Positive but Currently Negative HLA Crossmatching. Page:448—454
80. Effect of High Dose (10, 000 IU) Epoetin Alfa (Espogen(R)) Therapy in CAPD Patients. Page:441—447
81. Randomized, Controlled Trial of Darbepoetin Alfa for the Treatment of Renal Anemia in Hemodialysis Patients. Page:429—440
82. The Effect of Increasing Needle Size on Dialysis Adequacy in Hemodialysis Patients. Page:422—428
83. The Effect of Massaging on Hemodialysis Shunt Occlusion. Page:414—421
84. Diagnostic Noninvasive Tests for Coronary Artery Disease in Chronic Renal Failure Patients. Page:407—413
85. Prevalence of Hypertension and Impact of Predialysis Systolic Blood Pressure on Cardiovascular Mortality in Chronic Hemodialysis Patients. Page:399—406
86. The Mathematical Model for Predicting the Probability of Minimal Change Nephrotic Syndrome Using Clinical Parameters. Page:390—398
87. Clinical Significance of Cystoscopy in the Evaluation of Isolated Asymptomatic Microscopic Hematuria. Page:384—389
88. Relationship between Serum Insulin-like Growth Factor-1 Concentration and Insulin Resistance in End-stage Renal Disease Patients. Page:375—383
89. Apoptosis in Autosomal Dominant Polycystic Kidney Disease. Page:366—374
90. Expression of Fas Ligand (FasL) in Normal Kidney and Experimental Acute Tubular Necrosis. Page:358—365
91. Role of Reactive Oxygen Species and Mitogen-activated Protein Kinases in 2, 3, 7, 8-tetrachlorodibinzo-p-dioxin-induced Fibronectin Secretion by MDCK Cells. Page:350—357
92. Significance of Insulin Resistance in Patients with Chronic Kidney Disease. Page:347—349
93. Retrospective Analysis of Factors Related with Renal Outcomes in Elderly Type 2 Diabetic Patients Including Advanced Diabetic Nephropathy. Page:80—89
94. Renoprotective Effect of the Combined Use of Steroid and Angiotensin II Receptor Blocker in IgA Nephropathy. Page:71—79
95. Clinical Manifestations of Acute Renal Failure with Loin Pain Developed after the Anaerobic Exercise. Page:64—70
96. The Usefulness of Measuring Urinary Proteins by SDS-PAGE in Children with Type I DM without Overt Proteinuria. Page:57—63
97. Affecting Factors on Endothelial Dysfunction in Diabetic End Stage Renal Disease Patients on Hemodialysis. Page:47—56
98. Renoprotective Effect of Angiotensin Converting Enzyme Inhibitor and Angiotensin Receptor Blocker in Chronic Uremic Rats: Comparison of Early Treatment with Delayed Treatment. Page:32—46
99. Effects of Renin-angiotensin System Blockade on Tubulointerstitial Lesions in Adriamycin-induced Nephropathy. Page:26—31
100. The Risk Factors and Natural History of Chronic Kidney Disease in Liver Transplant Recipients. Page:965—973
101. Non-Surgical Gene Transfer to Rabbit Renal Glomeruli via Percutaneous Arterial Catheterization. Page:19—25
102. Altered Expression of Peritoneal Aquaporin-1 and Water Transport during Long-term Peritoneal Dialysis in Rats. Page:10—18
103. Effects of Indomethacin on Aquaporin Water Channels in Rat Kidney. Page:4—9
104. Cardiac Dysfunction in Predialysis Patients. Page:1—3
105. Four Cases of Verapamil Deleterious Effects in Chronic Renal Failure. Page:501—509
106. A Case of Pure Red Cell Aplasia Due to Parvovirus B19 Infection in a Renal Transplant Recipient. Page:494—500
107. A Case of Retransplantation in A Patient with Graft Loss Caused by Polyoma Virus Nephropathy. Page:489—493
108. A Case of Idiopathic Erythrocytosis in a CAPD Patient. Page:485—488
109. A Case of Pulmonary Hemorrhage Associated with IgA Nephropahty in Adult. Page:481—484
110. A Case of Recurrent Renal Infarction Due to Fibromuscula Dysplasia. Page:475—480
111. A Case of Carbamazepine-induced Acute Interstitial Nephritis. Page:470—474
112. A Case of Leriche Syndrome Manifested by Anuria. Page:464—469
113. Multiple Renal Abscess by Extended-Spectrum beta-Lactamase Producing Escherichia coli. Page:460—463
114. The Relation between Rhabdomyolysis and Microscopic Hematuria in Doxylamine Ingested Patients. Page:618—625
115. Clinical Outcomes in HLA-Identical Living-related Donor Renal Transplants. Page:611—617
116. Clinical Characteristics and Long-term Outcome of Glomerulonephritis in Renal Allografts. Page:603—610
117. Why are Diabetic Patients Requiring Hypertonic Glucose Dialysate to Achieve Comparable Ultrafiltration Volume During CAPD?. Page:594—602
118. The Association between 24-hour Ambulatory Blood Pressure Monitoring Parameters and Plsam Atrial Natriuretic Peptide in CAPD Patients. Page:586—593
119. Impact of Insulin Resistance on Glycemic Control in Diabetic End Stage Renal Disease Patients on Hemodialysis. Page:577—585
120. Genetic and Environmental Factors that Influence on Erythropoietin Resistance in Patients on Hemodialysis. Page:570—576
121. Factors Associated with Anti-HBs Antibody Titers in Hemodialysis Patients. Page:559—569
122. Role of Urinary N-acetyl-beta-D- glucosaminidase Level in Prediction of Pathological Tubular Lesion and Prognosis in Subclinical Asymptomatic IgA Nephropathy. Page:549—558
123. Rat Organic Anion Transporter 3 Co-localized with Caveolin-2 in Rat Kidney. Page:537—548
124. The Anti-inflammatory Effect of Rosiglitazone on Renal Injury in Sepsis Model. Page:526—536
125. The Effects of Maturation Resistant Donor Dendritic Cells on Alloimmune Response in Mice. Page:514—525
126. Dendritic Cells, Regulatory Cells, and Immunoiogical, Tolerance to Alloantigen. Page:511—513
127. A Case of Nephrocolic Fistula Associated with Staghorn Calculi. Page:1045—1049
128. A Case of Ethylene Glycol Poisoning with Metabolic Acidosis Treated with Hemodialysis. Page:1039—1043
129. A Case of Trimethoprim-Sulfamethoxazole and Omeprazole Induced Acute Interstitial Nephritis in a Patient with Renal Transplantation. Page:1033—1037
130. Tuberculous Pyomyositis in a Renal Transplant Patient. Page:1027—1031
131. Delayed Maturation of Arteriovenous Fistula due to Radial Artery Obstruction in a Patient Receiving Radiocephalic Arteriovenous Fistula. Page:1023—1026
132. Idiopathic Retroperitoneal Fibrosis Treated with High Dose Steroids. Page:1017—1021
133. A Case of Bilateral Psoas Abscess Complicated by Acute Pyelonephritis due to Klebsiella Pneumoniae. Page:1011—1015
134. A Case of Acute Renal Failure Resulting from Murine Typhus Infection Induced Acute Tubulointerstitial Nephritis. Page:1005—1009
135. A Case of Hemolytic Uremic Syndrome associated with EB Virus Infection. Page:999—1003
136. A Case of Microscopic Polyangiitis with Ischemic Colitis. Page:993—998
137. A Case of Aortic Arch Thrombus Associated with Acute Pyelonephritis in a Patient with Thrombocythemia. Page:987—991
138. End-stage Renal Disease Caused by Primary Hyperoxaluria. Page:981—985
139. A Case of C1q Mediated Glomerulonephritis Manifested by Asymptomatic Hematuria. Page:975—979
140. Measurement of Serum Ionized Magnesium in Dialysis Patients. Page:957—963
141. Clinical Significance of Routine Fistulography at Postoperative 1 Month in Patients Receiving Native Arteriovenous Fistula. Page:951—956
142. Is the Angiodysplasia Significant as the Cause of Upper Gastrointestinal Hemorrhage in Patients with Chronic Renal Failure?. Page:941—950
143. Correlationship between Homocysteine and Cardiac Troponin-I with Left Ventricular Hypertrophy in End-Stage Renal Disease Patients. Page:929—939